Phenylketonuria: An Inborn Error of Phenylalanine Metabolism

Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine (Phe) metabolism resulting from deficiency of phenylalanine hydroxylase (PAH). Most forms of PKU and hyperphenylalaninaemia (HPA) are caused by mutations in the PAH gene on chromosome 12q23.2. Untreated PKU is associated w...

Full description

Bibliographic Details
Main Authors: Williams, R., Mamotte, Cyril, Burnett, J.
Format: Journal Article
Published: The Australasian Association of Clinical Biochemists Inc. 2008
Online Access:http://hdl.handle.net/20.500.11937/44157
_version_ 1848756916772143104
author Williams, R.
Mamotte, Cyril
Burnett, J.
author_facet Williams, R.
Mamotte, Cyril
Burnett, J.
author_sort Williams, R.
building Curtin Institutional Repository
collection Online Access
description Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine (Phe) metabolism resulting from deficiency of phenylalanine hydroxylase (PAH). Most forms of PKU and hyperphenylalaninaemia (HPA) are caused by mutations in the PAH gene on chromosome 12q23.2. Untreated PKU is associated with an abnormal phenotype which includes growth failure, poor skin pigmentation, microcephaly, seizures, global developmental delay and severe intellectual impairment. However, since the introduction of newborn screening programs and with early dietary intervention, children born with PKU can now expect to lead relatively normal lives. A better understanding of the biochemistry, genetics and molecular basis of PKU, as well as the need for improved treatment options, has led to the development of new therapeutic strategies.
first_indexed 2025-11-14T09:19:48Z
format Journal Article
id curtin-20.500.11937-44157
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:19:48Z
publishDate 2008
publisher The Australasian Association of Clinical Biochemists Inc.
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-441572017-01-30T15:12:29Z Phenylketonuria: An Inborn Error of Phenylalanine Metabolism Williams, R. Mamotte, Cyril Burnett, J. Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine (Phe) metabolism resulting from deficiency of phenylalanine hydroxylase (PAH). Most forms of PKU and hyperphenylalaninaemia (HPA) are caused by mutations in the PAH gene on chromosome 12q23.2. Untreated PKU is associated with an abnormal phenotype which includes growth failure, poor skin pigmentation, microcephaly, seizures, global developmental delay and severe intellectual impairment. However, since the introduction of newborn screening programs and with early dietary intervention, children born with PKU can now expect to lead relatively normal lives. A better understanding of the biochemistry, genetics and molecular basis of PKU, as well as the need for improved treatment options, has led to the development of new therapeutic strategies. 2008 Journal Article http://hdl.handle.net/20.500.11937/44157 The Australasian Association of Clinical Biochemists Inc. restricted
spellingShingle Williams, R.
Mamotte, Cyril
Burnett, J.
Phenylketonuria: An Inborn Error of Phenylalanine Metabolism
title Phenylketonuria: An Inborn Error of Phenylalanine Metabolism
title_full Phenylketonuria: An Inborn Error of Phenylalanine Metabolism
title_fullStr Phenylketonuria: An Inborn Error of Phenylalanine Metabolism
title_full_unstemmed Phenylketonuria: An Inborn Error of Phenylalanine Metabolism
title_short Phenylketonuria: An Inborn Error of Phenylalanine Metabolism
title_sort phenylketonuria: an inborn error of phenylalanine metabolism
url http://hdl.handle.net/20.500.11937/44157